Covaxine Trials On Macau Monkeys, Yielding Positive Results

Covaxine trials on Macau monkeys yielding positive results, a huge increase in immunity. According to Bharat Biotech, the trials being conducted on vaccine animals being developed for the diagnosis of corona have produced better results.

Developed by ICMR and Bharat Biotech, the Covaxine trials saw a huge increase in immunity in Macau monkeys. These monkeys not only developed the ability to fight the virus after the vaccination of covaxine but also showed a significant decrease in the growth of the virus in the nose, throat.

Not only this, but it has also been found in the study that none of the monkeys developed pneumonia symptoms. Let us know that the trial of Covaxine is going on in 12 medical institutes of the country. It has seen very good results in the initial stages of the trial.

Meanwhile, the trial of the vaccine developed by the joint effort of Oxford University and pharmaceutical company AstraZeneca has been resumed. It was given the green signal to restart it after Britain declared the trial as safe. During a vaccine trial, trials were stopped for a volunteer following severe symptoms.

Meanwhile, the trial of the vaccine developed by the joint effort of Oxford University and pharmaceutical company AstraZeneca has been resumed. It was given the green signal to restart it after Britain declared the trial as safe. Trials were stopped for a few days when a volunteer involved in the trial of this vaccine caused severe symptoms.

On the other hand, the Drugs Controller General of India (DCGI) has asked the Serum Institute of India to put a moratorium on the induction of new people in the second and third phase trials of the Oxford AstraZeneca vaccine until further orders. The order has been issued under Rule 30 of the New Drugs and Clinical Trials Rules-2019.